GIT2: Key Regulator of DNA-Protein Binding and Cellular Processes

Target Name: GIT2

NCBI ID: G9815

GIT2: Key Regulator of DNA-Protein Binding and Cellular Processes

GIT2 (Gene-Integrated Targets 2) is a protein that is expressed in a variety of tissues and cells, including neurons, muscle cells, and leukemia cells. It is a key regulator of the DNA-protein binding complex known as the N-end rule, which is involved in the regulation of gene expression. GIT2 has also been shown to play a role in the development and progression of various diseases, including cancer. As a result, GIT2 has generated a lot of interest as a potential drug target or biomarker.

The N-end rule is a complex of proteins that helps to ensure that the N-terminus of a protein is added to the protein via a process called post-translational modification (PTM). This modification can include adding a phosphate group, which can modulate the activity of the protein and influence its stability or localization. GIT2 is one of the key proteins that is involved in the N-end rule. It is a 25kDa protein that is composed of a 19kDa N-terminal region, a 7kDa middle region , and a 90kDa C-terminal region.

GIT2 is expressed in a variety of tissues and cells, including neurons, muscle cells, and leukemia cells. It is highly enriched in the brain, where it is found in the postsynaptic terminal of dendrites in neurons. It is also expressed in other tissues, including the placenta, where it is involved in the regulation of gene expression in developing fetal tissues.

GIT2 has been shown to play a role in the regulation of gene expression in various organisms. For example, GIT2 has been shown to be involved in the regulation of the expression of the gene encoding the protein Pyroglobin (PG). PG is a heme- protein that is involved in the production of reactive oxygen species (ROS), which can damage cellular components and contribute to the development of various diseases, including cancer. GIT2 has been shown to play a role in the regulation of PG expression by modulating the activity of the transcription factor NF-kappa-B.

In addition to its role in the regulation of gene expression, GIT2 has also been shown to be involved in the regulation of cellular processes that are important for the development and progression of various diseases, including cancer. For example, GIT2 has been shown to play a role in the regulation of cell migration, which is a critical process for the development of cancer cells. GIT2 has been shown to regulate the migration of cancer cells by modulating the activity of the protein FAK.

GIT2 has also been shown to play a role in the regulation of the cytoskeleton, which is a structure that is important for the proper functioning of cells. The cytoskeleton is made up of a variety of proteins that help to maintain the shape and stability of the cell, as well as play a role in the movement of cells and the formation of tissues. GIT2 has been shown to regulate the cytoskeleton by modulating the activity of the protein tubulin (MAPK/ERK1/2).

GIT2 has also been shown to play a role in the regulation of cellular signaling pathways that are important for the development and progression of various diseases, including cancer. is responsible for the regulation of cell growth and the apoptosis (programmed cell death). GIT2 has been shown to regulate the activity of the protein

Protein Name: GIT ArfGAP 2

Functions: GTPase-activating protein for ADP ribosylation factor family members, including ARF1

More Common Targets